BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22988919)

  • 1. Development of copper-catalyzed azide-alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation.
    Nairn NW; Shanebeck KD; Wang A; Graddis TJ; VanBrunt MP; Thornton KC; Grabstein K
    Bioconjug Chem; 2012 Oct; 23(10):2087-97. PubMed ID: 22988919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent effect on copper-catalyzed azide-alkyne cycloaddition (CuAAC): synthesis of novel triazolyl substituted quinolines as potential anticancer agents.
    Ellanki AR; Islam A; Rama VS; Pulipati RP; Rambabu D; Krishna GR; Reddy CM; Mukkanti K; Vanaja GR; Kalle AM; Kumar KS; Pal M
    Bioorg Med Chem Lett; 2012 May; 22(10):3455-9. PubMed ID: 22516283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
    Lee JI; Eisenberg SP; Rosendahl MS; Chlipala EA; Brown JD; Doherty DH; Cox GN
    J Interferon Cytokine Res; 2013 Dec; 33(12):769-77. PubMed ID: 23962003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring protein-polymer conjugation by a fluorogenic Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition.
    Dirks AT; Cornelissen JJ; Nolte RJ
    Bioconjug Chem; 2009 Jun; 20(6):1129-38. PubMed ID: 19453101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of copper(I) catalyzed azide-alkyne [3+2] cycloaddition to the synthesis of template-assembled multivalent peptide conjugates.
    Avrutina O; Empting M; Fabritz S; Daneschdar M; Frauendorf H; Diederichsen U; Kolmar H
    Org Biomol Chem; 2009 Oct; 7(20):4177-85. PubMed ID: 19795056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From mechanism to mouse: a tale of two bioorthogonal reactions.
    Sletten EM; Bertozzi CR
    Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Mechanism of Copper(I)-Catalyzed Azide-Alkyne Cycloaddition.
    Zhu L; Brassard CJ; Zhang X; Guha PM; Clark RJ
    Chem Rec; 2016 Jun; 16(3):1501-17. PubMed ID: 27216993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine as a Monothiol Reducing Agent to Prevent Copper-Mediated Oxidation of Interferon Beta During PEGylation by CuAAC.
    Nairn NW; Bariola PA; Graddis TJ; VanBrunt MP; Wang A; Li G; Grabstein K
    Bioconjug Chem; 2015 Oct; 26(10):2070-5. PubMed ID: 26439457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating Strain-Promoted Azide-Alkyne Cycloaddition Using Micellar Catalysis.
    Anderton GI; Bangerter AS; Davis TC; Feng Z; Furtak AJ; Larsen JO; Scroggin TL; Heemstra JM
    Bioconjug Chem; 2015 Aug; 26(8):1687-91. PubMed ID: 26056848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-promoted alkyne azide cycloaddition for the functionalization of poly(amide)-based dendrons and dendrimers.
    Ornelas C; Broichhagen J; Weck M
    J Am Chem Soc; 2010 Mar; 132(11):3923-31. PubMed ID: 20184364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal chelating systems synthesized using the copper(I) catalyzed azide-alkyne cycloaddition.
    Struthers H; Mindt TL; Schibli R
    Dalton Trans; 2010 Jan; 39(3):675-96. PubMed ID: 20066208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of Cu (I)-catalyzed alkyne-azide cycloaddition (CuAAC) and strain-promoted alkyne-azide cycloaddition (SPAAC) in O-GlcNAc proteomics.
    Li S; Zhu H; Wang J; Wang X; Li X; Ma C; Wen L; Yu B; Wang Y; Li J; Wang PG
    Electrophoresis; 2016 Jun; 37(11):1431-6. PubMed ID: 26853435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition.
    Wang Q; Chan TR; Hilgraf R; Fokin VV; Sharpless KB; Finn MG
    J Am Chem Soc; 2003 Mar; 125(11):3192-3. PubMed ID: 12630856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A facile route to viologen functional macromolecules through azide-alkyne [3+2] cycloaddition.
    Janeček ER; Rauwald U; del Barrio J; Cziferszky M; Scherman OA
    Macromol Rapid Commun; 2013 Oct; 34(19):1547-53. PubMed ID: 23996858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Applications of the Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) as a Bioorthogonal Reaction.
    Li L; Zhang Z
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27783053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of click chemistry to the production of DNA microarrays.
    Uszczyńska B; Ratajczak T; Frydrych E; Maciejewski H; Figlerowicz M; Markiewicz WT; Chmielewski MK
    Lab Chip; 2012 Mar; 12(6):1151-6. PubMed ID: 22318451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of protein-cage-based delivery nanoplatforms by polyvalently displaying β-cyclodextrins on the surface of ferritins through copper(I)-catalyzed azide/alkyne cycloaddition.
    Kwon C; Kang YJ; Jeon S; Jung S; Hong SY; Kang S
    Macromol Biosci; 2012 Nov; 12(11):1452-8. PubMed ID: 22965861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome functionalization with copper-free "click chemistry".
    Oude Blenke E; Klaasse G; Merten H; Plückthun A; Mastrobattista E; Martin NI
    J Control Release; 2015 Mar; 202():14-20. PubMed ID: 25626085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.